Clinical Trial Update: Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

Update on a pirfenidone trial investigating treatment of skin fibrosis in systemic sclerosis (Phase 2 and Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: RenJi Hospital | Conditions: Systemic Sclerosis | Phase 2, Phase 3 | Status: UNKNOWN